MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Bayer Canada is pleased to announce a new partnership with Mint Pharmaceuticals Inc. for the distribution of ADALAT ® XL ® 30 mg tablets 1 in Canada. This ...

ADALAT® XL® (nifedipine extended-release tablets) first received market authorization in Canada in 1995 and is indicated for the management of chronic stable angina and the management of mild to ...

ADALAT® XL® (nifedipine extended-release tablets) first received market authorization in Canada in 1995 and is indicated for the management of chronic stable angina and the management of mild to ...

From Left to right: Olenka Crewe, VP of Business Development & Scientific Affairs, Mint Pharmaceuticals, Jaiveer Singh, CEO Mint Pharmaceuticals, Viktoria Friedrich, Country President and General ...

ADALAT ® XL ® (nifedipine extended-release tablets) first received market authorization in Canada in 1995 and is indicated for the management of chronic stable angina and the management of mild to ...

ADALAT ® XL ® (nifedipine extended-release tablets) first received market authorization in Canada in 1995 and is indicated for the management of chronic stable angina and the management of mild to ...

The U.S. Food and Drug Administration today approved ellaTM (ulipristal acetate) tablets for emergency contraception. The prescription-only product prevents pregnancy when taken orally within 120 ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (FDA) for diltiazem hydrochloride tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg (USRLD: ...

Paroxetine is prescribed to treat certain mental health conditions, such as major depressive disorder (commonly known as depression), obsessive-compulsive disorder (OCD), and social anxiety disorder.

Nora Pharma is recalling one lot of NRA-Amlodipine 5 mg tablets because some bottles may contain the wrong tablets, which have been identified as metoprolol succinate prolonged–release 12.5 mg tablets ...